A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...

Popular weight loss drugs such as Wegovy and Zepbound have shown incredible success in clinical trials. But in the real world ...

Real-world cost barriers and insurance denials contribute to early discontinuation of injectable glucagon-like peptide-1 (GLP ...

Jenna Bush Hager's new hairstyle, the winners of Shop TODAY's 2025 Beauty Awards, and a new study about whether GLP-1 drugs ...

In March, the Food and Drug Administration approved Vykat XR, an extended-release version of the existing drug diazoxide choline, which eases the relentless hunger and may offer insights into the ...

When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, one method led to much more weight loss.

GLP-1 drugs show promise in diabetes management, offering heart and kidney benefits, but also highlight the need for ...

Many focus on what weight-loss drugs take away: pounds. But they also offer patients something new: a sense of agency.

As more CFOs step into the public spotlight by participating in events and conferences, the cost of misspeaking and the importance of leadership alignment on policy are increasing.

Dr. David A. Kessler tested GLP-1 drugs to shed some pounds over seven months and found there was one rather uncomfortable ...

China now offers a dizzyingly abundant source of innovative, high-quality therapies at—by pharma standards—reasonable prices.

New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...